Medicus Pharma Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MDCX | JNJ | BIIB | JNJ.NE | SNGX | PMCB | |
|---|---|---|---|---|---|---|
| Market cap | 3.57M | 665.19B | 37.61B | 915.54B | 7.64M | 4.09M |
| P/E (TTM) | — | 41.9 | 110.2 | 25.4 | — | — |
| Forward P/E | -0.1 | 23.8 | 15.6 | — | -1.4 | -1.0 |
| Price/book | -1.3 | 8.2 | 2.0 | 0.8 | 1.1 | 0.1 |
| Dividend yield | — | 1.94% | — | 2.49% | — | — |
| 1-year change | −98.23% | +43.10% | +62.24% | +40.84% | −73.91% | −61.58% |
| Today | −7.39% | +3.81% | +2.22% | +4.32% | −1.49% | +12.03% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All MDCX news ›Medicus Pharma plans SPAC listing for SkinJect unit at $135 million valuation
Medicus Pharma (NASDAQ:MDCX) said on Wednesday its wholly owned subsidiary SkinJect Inc. has signed a non-binding letter of intent with an undisclosed special purpose acquisition company for a business combination valuing SkinJect at $135…
Medicus Pharma jumps as SkinJect explores $135M SPAC deal
Medicus Pharma’s SkinJect signed an LOI with a SPAC on a $135M deal to fund its Gorlin syndrome study and NDA prep. MDV Edwards/iStock Editorial via Getty Images - Medicus Pharma (MDCX) announced Wednesday that its wholly owned subsidiary,…
Medrio Launches New CTMS as First Step Toward One Connected Clinical Trial Platform
Nov 03, 2026, 08:30 ET Medrio CTMS, built for small and scaling sponsors and CROs, is available now through the Early Adopter Program ahead of general availability in early 2027. SAN FRANCISCO, Nov. 3, 2026 /PRNewswire/ - Medrio, a…
MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market
WSW, NY, April 23rd, 2026, FinanceWire A 60-Year-Old Drug vs. a 5-Day Solution: Why Wound Care Giants Are Watching MediWound Recent News Highlights from MediWound (MDWD) Newly Published U.S. Expert Consensus Aligns with MediWound’s…
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
BioSpace Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (NASDAQ: PSNL) announced today
Medicenna Therapeutics Raises $4.4M Via Public Offering of Units
Medicenna Therapeutics closed its previously announced marketed public offering of units at $0.50 apiece, for about $4.44 million, before deducting offering expenses and excluding any proceeds the... Biotechnology & Medical Research…
Medicus Pharma CEO to present precision oncology progress at global biotech conferences
Medicus Pharma (NASDAQ:MDCX) CEO Dr Raza Bokhari will present at BioFuture 2026 in New York and deliver a keynote at the Global Biotechnology Summit 2026 in Abu Dhabi. Bokhari will join a BioFuture panel today titled “Beyond the Cure: The…
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Join the community built by investors, for investors. Create your free account » The Compliance Notice relates specifically to the minimum bid price requirement. The Company remains subject to Nasdaq’s other continued listing requirements,…
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
This transformation, outlined in our recent strategic update, reflects progress in clinical advancement, strategic acquisitions, and investment in the people and capabilities needed to execute. From a company centered on SkinJect, we have…
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
Following FDA feedback, and subject to the nature of that feedback, Medicus’ intent is to seek to out-license or otherwise strategically partner the Teverelix APC program rather than independently fund execution of the proposed…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- markets.businessinsider.com6
- proactiveinvestors.com3
- seekingalpha.com3
- stocktitan.net3
- mychesco.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.